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Abstract
The H-ATPase from chloroplasts, CF0F1, was isolated and purified. The enzyme contained one endogenous ADP at a
catalytic site, and two endogenous ATP at non-catalytic sites. Incubation with 2-azido-[K-32P]AD(T)P leads to a tight
binding of the azido-nucleotides. Free nucleotides were removed by three consecutive passages through centrifugation
columns, and after UV-irradiation, the label was covalently bound. The labelled enzyme was digested by trypsin, the peptides
were separated by ion exchange chromatography into nitreno-AMP, nitreno-ADP and nitreno-ATP labelled peptides, and
these were then separated by reversed phase chromatography. Amino acid sequence analysis was used to identify the type of
the nucleotide binding site. After incubation with 2-azido-[K-32P]ADP, the covalently bound label was found exclusively at
L-Tyr-362, i.e. binding occurs only to catalytic sites. Incubation conditions with 2-azido-[K-32P]ADP were varied, and
conditions were found which allow selective binding of the label to different catalytic sites, either to catalytic site 2 or to
catalytic site 3. For measurements of the degree of inhibition by covalent modification, CF0F1 was reconstituted into
phosphatidylcholine liposomes, and the membranes were energised by an acid-base transition in the presence of a K/
valinomycin diffusion potential. The rate of ATP synthesis was 120 s31, and the rate of ATP hydrolysis was 20 s31, both
measured under multi-site conditions. Covalent modification of either catalytic site 2 or catalytic site 3 inhibited both ATP
synthesis and ATP hydrolysis, the degree of inhibition being proportional to the degree of modification. Extrapolation to
complete inhibition indicates that modification of one catalytic site, either site 2 or site 3, is sufficient to completely block
multi-site ATP synthesis and ATP hydrolysis. The rate of ATP synthesis and the rate of ATP hydrolysis were measured as a
function of the substrate concentration from multi-site to uni-site conditions with covalently modified CF0F1 and with non-
modified CF0F1. The result was that uni-site ATP synthesis and ATP hydrolysis were not inhibited by covalent modification
of either catalytic site 2 or site 3. The results indicate cooperative interactions between catalytic nucleotide binding sites
during multi-site catalysis, whereas neither uni-site ATP synthesis nor uni-site ATP hydrolysis require interaction with other
sites. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
F-type H-ATPases catalyse ATP synthesis and
ATP hydrolysis coupled with a transmembrane pro-
ton transport in bacteria, chloroplasts and mitochon-
dria [1,2]. These enzymes contain a membrane-in-
serted F0-part involved in proton translocation and
a hydrophilic F1-part containing six nucleotide bind-
ing sites [3^7]. Photolabile as well as chemically re-
active nucleotide analogues have been used to iden-
tify the nucleotide binding sites within the protein [8].
2-Azido-AD(T)P has been frequently used since it
has the same ‘anti’ conformation as the adenine nu-
cleotides, and its photolabile group is small, so that
binding to the enzyme is not disturbed [8]. Thus, the
analogue binds to F-ATPases with similar character-
istics as AD(T)P, and it is a substrate for both ATP
synthesis and ATP hydrolysis with almost the same
KM values as those of the corresponding adenine
nucleotides [9^11].
CF0F1 embedded in thylakoid membranes binds
2-azido-AD(T)P in such a way that, after formation
of a covalent bond upon photolysis, exclusively
L-subunits are modi¢ed [12]. In order to distinguish
between catalytic and non-catalytic binding sites, a
detailed analysis of binding to isolated CF1 under
di¡erent conditions was carried out by Boyer’s
group: Binding to catalytic sites, followed by UV-
irradiation, labels covalently Tyr-362 of the L-sub-
unit. Binding to non-catalytic sites results in the
labelling of Tyr-385 of the L-subunit [13,14]. This
surprising result was understood after the elucidation
of the structure of MF1 [15]: the catalytic sites are
located on L-subunits, and L-Tyr-362 (CF1 number-
ing) is located near the azido-group of 2-azido-ADP
when bound at a catalytic site. The nucleotide bind-
ing sites on the K-subunits, however, do not only
contain amino acids from the K-subunit, but also a
loop from a L-subunit contributes to the binding
pocket, and this loop contains L-Tyr-385, located
near the azido group of 2-azido-ADP bound at the
K-subunit. It has been concluded from the experi-
mental conditions for speci¢c labelling [13,14] as
well as from the structural data of the nucleotide
binding sites on K- and L-subunits, that catalysis
can only occur at L-sites, while the K-sites are non-
catalytic [15].
The interaction between the di¡erent sites is still
under debate. The most favoured opinion is that all
three L-sites participate equally in multi-site cataly-
sis : at each moment, the three sites have a di¡erent
structure, but during catalysis, they undergo confor-
mational changes, adopting the open, tight and loose
conformation in sequential order [16,17]. An alterna-
tive proposal is that only two L-sites are directly in-
volved in multi-site catalysis, one site containing a
tightly bound nucleotide in MF1 [18,19] or turning
over very slowly in CF1F0 [20,21]. When catalytic
sites operate sequentially, covalent modi¢cation of
one site is expected to block enzyme activity com-
pletely. Earlier studies on the correlation between
derivatisation of F1-ATPases from di¡erent sources
and the inhibition of ATP hydrolysis were reviewed
in [22]. Covalent derivatisation of one site (full inhib-
ition, partial inhibition, no inhibition) might lead to
di¡erent e¡ects on the rate catalysed by the non-de-
rivatised sites. In addition, covalent modi¢cation of
one catalytic site of CF1 with 2-azido-ATP does not
cause a complete loss of enzymatic activity, and addi-
tional 18O measurements indicate formation of cata-
lytic sites with altered properties [23]. Furthermore, it
must be taken into account that not in all cases re-
ported in literature (for review see [22]) only one type
of nucleotide binding site was derivatised. These ob-
servations impede the interpretation of the correla-
tion between activity and enzyme modi¢cation. For a
mechanistic interpretation, there are two additional
problems. First, most of the work with covalent la-
belling of nucleotide binding sites was not carried out
with the holoenzyme, but with the experimentally
more amenable F1 part. F1-catalysed ATP hydrolysis
only gives information on a partial reaction of the
enzyme and it is important to know, how catalytic
sites interact, when ATP synthesis and ATP hydro-
lysis are coupled with proton transport. Second, a
special problem arises with the chloroplast enzyme,
since CF1 is usually obtained in an inactive latent
form and requires one or other special (mis-) treat-
ment in order to induce ATP hydrolysis activity.
Such treatments might generate a heterogeneity of
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the enzymes and/or a heterogeneity of catalytic path-
ways.
Puri¢ed CFoF1 can be reconstituted into lipo-
somes, and, after energisation of the membrane by
vpH/vB, the rate of ATP synthesis is almost as high
as in thylakoid membranes [24]. In this system, it is
possible to correlate the e¡ect of covalent modi¢ca-
tion with the inhibition of the complete reaction
cycle including H translocation. Therefore, we de-
cided to investigate the correlation between covalent
derivatisation and ATP synthesis with reconstituted
CF0F1 and to pay special attention to derivatise only
one type of nucleotide binding site.
The binding of nucleotides to the di¡erent catalytic
and non-catalytic sites of CF1 has been extensively
studied [25,26]. Based on this work, we have devel-
oped procedures which allow selective binding of 2-
azido AD(T)P to the di¡erent nucleotide binding
sites of CF0F1. In this report, the three sites on the
L-subunits will be called sites 1, 2 and 3 in order of
decreasing a⁄nity, as has been done with mitochon-
drial F1 [27]. Correspondingly, the three K-sites are
called sites 4, 5 and 6 in order of decreasing a⁄nity.
In this work we report on selective binding of 2-azi-
do-ADP to site 2 and to site 3, and on the e¡ect of
covalent labelling of these sites on ATP hydrolysis
and ATP synthesis.
2. Materials and methods
2.1. Preparation of CF0F1
The H-ATPase from chloroplasts was isolated
and puri¢ed as described earlier [28,29], with the ex-
ception that no nucleotides were present in the su-
crose-density gradient centrifugation. After puri¢ca-
tion, the enzyme was obtained in a solution
containing 300 g/l sucrose, 30 mM Tris-succinate,
pH 6.5, 0.5 mM EDTA, 2 g/l Triton X-100 (Sigma)
and 1 g/l asolectin (soy bean lecithin, Fluka). The
solution was rapidly frozen and stored in liquid ni-
trogen. Protein concentration was measured with the
Bio-Rad protein assay using bovine serum albumin
as a standard. A molecular mass of 550 000 Da for
the CF0F1 was assumed.
2.2. Synthesis of 2-azido-[K-32P]AT(D)P
The synthesis of 2-azido-[K-32P]AD(T)P was per-
formed as described in [30] with some modi¢cations
[31]. All preparations were used as triethylammo-
nium salt solution in H2O. The speci¢c activity in
the preparations was 900^1000 dpm/pmol shortly
after the synthesis. The 2-azido-[K-32P]ADP con-
tained approximately 0.5% 2-azido-[K-32P]ATP, max-
imally 1%.
2.3. Incubation with 2-azido-[K-32P]AD(T)P
The isolated and puri¢ed CF0F1 at a concentration
of 2^3 g/l was separated from free and loosely bound
nucleotides by three consecutive passages through
Sephadex G-50 centrifugation columns [32] equili-
brated in bu¡er A: 20 mM Na-succinate, 20 mM
Na-Tricine, pH 8.0, 80 mM NaCl. The enzyme was
incubated with 2-azido-[K-32P]AD(T)P at room tem-
perature in the dark in bu¡er A in the presence of
either 2 mM EDTA or 2 mM MgCl2. After incuba-
tion, free and loosely bound nucleotides were re-
moved by three consecutive passages through Sepha-
dex G-50 centrifugation columns. Free and bound
ADP and ATP were determined with the luciferin/
luciferase assay as described in [21]. Bound 2-azido-
[K-32P]AD(T)P was determined by the 32P content
and measured either as Cerenkov radiation or by
liquid scintillation counting in a LKB 1214 Rackbeta
scintillation counter.
2.4. Photoa⁄nity labelling
After removal of free and loosely bound 2-azido-
[K-32P]ADP, samples of 300 Wl were placed in a glass
cuvette (optical pathway 2^3 mm) covered with a
quartz plate. The solution was irradiated by a
UV-lamp (Pen-Ray, Type 11SC-1, Ultra-Violet
Products), placed 1.5 cm above the sample. To
measure the fraction of the covalently bound nucleo-
tides, the enzyme was precipitated and washed twice
with 4% perchloric acid. After solubilisation in
200 mM NaOH and 0.1% sodium dodecylsulfate,
the radioactivity and the protein content were meas-
ured.
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2.5. Identi¢cation of the modi¢ed binding site
The labelled enzyme was treated with trypsin as
described in [14]. The peptides were then puri¢ed
by HPLC using ¢rst an ion exchange column and
subsequently a reversed phase column [19,33]. The
ion exchange column (Whatman Partisil PX S25/
SAX10) was eluted with a linear gradient of 0.01 M
sodium phosphate (pH 4.0, eluent A) and 0.4 M
sodium phosphate (pH 3.0, eluent B), both mixed
with acetonitrile in a ratio of 71:29, with a £ow
rate of 1.25 ml/min. The column was run with
LKB 2150 HPLC pumps with a gradient mixer, op-
erated by a LKB 2151 controller. Protein was de-
tected at 215 nm with a Pharmacia/LKB VWM
2141 detector. Radioactivity in the collected fractions
(1.25 ml) was determined by Cerenkov radiation.
Fractions containing protein and radioactivity were
further puri¢ed on a Vydac C4 reversed phase col-
umn eluted with a non-linear gradient, as shown in
Fig. 5. Eluent A was 0.1% tri£uoroacetic acid in
water and eluent B 0.1% tri£uoroacetic acid and
90% acetonitrile in water. The column was operated
with the same set-up as mentioned before, but with a
£ow rate of 1.1 ml/min. The fractions (1.1 ml) were
lyophilised. Amino acid sequence analysis of the la-
belled peptides was performed by automated Edman
degradation using a Porton analyser (Beckman).
2.6. Reconstitution of CF0F1 into liposomes
The reconstitution of CF0F1 into liposomes was
performed by the Biobeads technique as described
earlier [34], using the following reconstitution bu¡er:
20 mM Na-Tricine, 20 mM Na-succinate, 80 mM
NaCl, 0.6 mM KOH, pH 8.0. The lipid concentra-
tion of the proteoliposome suspension in the recon-
stitution mixture was 8 mg/ml, i.e. approximately
10 mM. The concentration of CF0F1 was 80 nM,
for measurements under multi-site conditions, and
800 nM for measurements under uni- and bi-site
conditions. After reconstitution, the enzyme was re-
duced by incubation with 50 mM dithiothreitol for
2 h at room temperature.
2.7. ATP synthesis
ATP synthesis was measured during a vpH/vB
jump [35] as described earlier [34]. In the acidic stage,
the medium contained 20 mM Na-succinate, 5 mM
NaH2PO4, 2.5 mM MgCl2 and 0.6 mM KOH, pH
4.7. Valinomycin (2 WM ¢nal concentration) was
added freshly. In the basic stage, the medium con-
tained 200 mM Na-tricine, 5 mM NaH2PO4, 2.5 mM
MgCl2, 120 mM KCl, pH 8.7 and di¡erent ADP
concentrations. The resulting pH of the internal
phase of the proteoliposomes was 4.9, and the exter-
nal pH value was 8.5. The ratio of internal K to
external K was 0.6 mM [K]in to 60 mM [K]out
resulting in a valinomycin-induced di¡usion poten-
tial, vB, of approximately 100 mV. After di¡erent
reaction times between 0.5 and 30 s, the proteolipo-
somes were denatured by trichloroacetic acid, and
the ATP concentration was measured by luciferin/
luciferase. ATP synthesis and detection of ATP
with the luciferin/luciferase assay were carried out
simultaneously in one step as follows: 200 Wl of the
basic medium with di¡erent ADP concentrations
were incubated in a luminometer cuvette with 50 Wl
ATP monitoring reagent (Bio-Orbit), and the base
line was recorded. Proteoliposomes (40 Wl, CF0F1
concentration either 80 nM or 800 nM) were incu-
bated for 2 min with 200 Wl of the acidic medium.
ATP synthesis was initiated by injection of 220 Wl of
the acidic proteoliposome suspension directly into
the basic medium. The increase of ATP concentra-
tion was followed by the increased light emission
with the Bio-Orbit luminometer. When the signal
reached a constant luminescence level, it was cali-
brated by addition of an ATP standard solution.
The rate of ATP synthesis was calculated from the
initial slope, which was constant for about 2 s (de-
pending on the ADP concentration).
2.8. ATP hydrolysis
ATP hydrolysis under multi-site conditions, with
1 mM [Q-32P]ATP, was measured as described in
[36]. Measurements of ATP hydrolysis in the pres-
ence of low ATP concentrations were performed in a
one-step procedure, similar to the one for ATP syn-
thesis. The hydrolysed ATP was detected directly
with the luciferin/luciferase assay. The cuvette con-
tained 220 Wl of bu¡er B (100 mM Na-tricine pH 8.5,
60 mM KOH, 2 mM NaH2PO4, 2 mM MgCl2,
20 mM NH4Cl, 300 mM LiCl, 10 nM-1 WM ATP)
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and 50 Wl ATP monitoring reagent (Bio-Orbit). The
base line was recorded, and the change of ATP con-
centration was followed by the change of the light
emission in the luminometer. In a reaction vial, 40 Wl
of proteoliposomes (CF0F1 concentration either
80 nM or 800 nM) were added to 80 Wl acidic so-
lution (20 mM Na-succinate, pH 4.7, 2 mM
NaH2PO4, 2 mM MgCl2, 0.6 mM KOH, 8 WM va-
linomycin). After 2 min incubation, 120 Wl of basic
solution (200 mM Na-tricine, pH 8.7, 2 mM
NaH2PO4, 2 mM MgCl2 120 mM KOH) were
added. After 15 s, 200 Wl of this mixture were in-
jected into a cuvette placed in the luminometer. Cal-
ibration was carried out by addition of an ATP
standard solution. The rate of ATP hydrolysis was
calculated from the initial slope of the luminescence
signal, which was constant for approximately 50 s.
2.9. Determination of released 2-azido-[K-32P]AXP
in a vpH/vB jump
The released 2-azido-[K-32P]AXP in a vpH/vB
jump was measured with a ¢ltration assay in synthe-
sis and hydrolysis direction. For measurements with-
out substrate, 40 Wl dithiothreitol-treated proteolipo-
somes with a CF0F1 concentration of about 500 nM
were incubated for 2 min in 200 Wl acidic medium.
Amounts of 240 Wl of a basic solution (without sub-
strate) were added. After 5 s of incubation, the ¢l-
trate was separated by using a 5-ml syringe with a
Dynagard ¢ltertip (type: DG2M-330-100, pore size
0.2 Wm, Tecnorama). The released 2-azido-[K-
32P]AXP was determined by liquid scintillation
counting of 100 Wl ¢ltrate in a LKB 1214 Rackbeta
scintillation counter. In order to measure the release
during catalytic turnover, the same experiment was
carried out in the presence of substrate, i.e. either
with addition of 100 WM ADP in the basic bu¡er
(synthesis direction) or with addition of 1 mM
ATP (hydrolysis direction). In the latter case, the
basic bu¡er contained additionally 20 mM NH4Cl
for uncoupling.
3. Results
3.1. Experimental protocol
CF0F1 was isolated and puri¢ed, and the free nu-
cleotides were removed by three consecutive passages
through centrifugation columns. After this treatment,
the enzyme contains about 1 ADP and 2 ATP per
CF0F1 (Table 1), and this enzyme was used for the
following experiments. Fig. 1 schematically shows
Fig. 1. Scheme of the experimental protocol for labelling of CF0F1, protein analysis and activity measurements. As additional con-
trols, the same treatments were carried out using ADP and ATP without 32P-label for incubation. Then the enzyme activities were
measured with and without UV-irradiation.
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the experimental protocol: CF0F1 was incubated ei-
ther with 2 mM MgCl2 or 2 mM EDTA and di¡er-
ent concentrations of 2-azido-[K-32P]ADP for up to
1.5 h at room temperature. After incubation, free
nucleotides were again removed by three consecutive
runs of centrifugation columns, and protein concen-
tration and bound nucleotides were determined.
Then a part of the enzyme solution with the bound
2-azido-[K-32P]ADP was irradiated with UV-light,
for covalent modi¢cation, and digested by trypsin.
The labelled peptides were separated by HPLC,
and the amino acid sequences of the peptides were
determined. In parallel, the irradiated and the non-
irradiated enzyme were reconstituted into liposomes.
Again the content of nucleotide and 2-azido-[K-
32P]ADP was determined, and ¢nally the rates of
ATP synthesis and ATP hydrolysis were measured
under uni-site to multi-site conditions. The same
measurements were carried out with the non-irradi-
ated sample of CFoF1, which contained non-cova-
lently bound 2-azido-[K-32P]AXP. Additionally, the
release of bound 2-azido-[K-32P]AXP was measured
after energisation in the presence as well as in the
absence of catalytic turnover.
As a control, isolated CF0F1 was either irradiated
with UV-light or not irradiated. Again, these en-
zymes were reconstituted into liposomes, and the nu-
cleotide content, ATP synthesis and ATP hydrolysis
were measured. Incubation with non-labelled nucleo-
tides before irradiation (in the same way as with 2-
azido-[K-32P]ADP) did not change the result of the
activity measurements.
3.2. Binding of 2-azido-[K-32P]ADP to the loose
binding site
When the protein was incubated for 30 min with
di¡erent concentrations of 2-azido-[K-32P]ADP in the
presence of 2 mM MgCl2 the results shown in Fig. 2
(upper panel) were obtained. About one 2-azido-[K-
32P]ADP per CF0F1 was bound under these condi-
tions. The content of endogenous ADP and ATP did
not change after about 30 min. With 20 WM ligand,
about 50% of this site became occupied. The total
nucleotide content (after three column centrifugation
steps) increased from 3 to 4 nucleotides per enzyme.
With 50 WM 2-azido-[K-32P]ADP in the presence of
2 mM MgCl2, the binding was complete after about
30 min, and neither the endogenous nucleotide con-
tent nor the 2-azido-[K-32P]ADP content was
changed during longer incubation times (Fig. 2,
lower panel). This treatment is called procedure 1
in Fig. 3, and leads to the occupation of binding
site 2 (loose site). When the incubation was per-
formed in the presence of EDTA for 30 min, the
same result was obtained. Fig. 3 schematically sum-
marises the di¡erent procedures used in this work for
speci¢c occupation of the binding sites. In order to
clarify the presentation, we have already included the
results for the other binding sites. Arguments for the
interpretation will be given later.
Fig. 2. Binding of 2-azido-[K-32P]ADP to CF0F1. Upper panel:
isolated CF0F1 (5 WM) was incubated with 2-azido-[K-32P]ADP
in the presence of 2 mM MgCl2 for 30 min, and free nucleoti-
des were removed by three consecutive passages through centri-
fugation columns. About one 2-azido-[K-32P]ADP was bound
per CF0F1 when the nucleotide concentration was higher than
50 WM. The initial nucleotide content (ADP and ATP) did not
change. The asterisks indicate the results of the incubation with
2-azido-[K-32P]ATP under the same conditions. Lower panel:
isolated CF0F1 (5 WM) was incubated with 50 WM 2-azido-[K-
32P]ADP in the presence of 2 mM MgCl2. Binding was com-
plete after about 30 min, the content of initially bound nucleo-
tides remained constant.
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3.3. E¡ect of covalent modi¢cation of the loose
binding site on enzyme activity
The enzyme with the loose binding site occupied
by 2-azido-[K-32P]ADP (procedure 1) was then irra-
diated with UV-light for up to 45 s, as described in
Section 2. After irradiation, the protein was dena-
tured, and the amount of covalently bound 2-nitre-
no-[K-32P]AXP was measured, as described in Sec-
tion 2. Fig. 4A shows the amount of covalently
bound 2-nitreno-[K-32P]ADP as a function of the ir-
radiation time. The data indicate that maximally
75% of the bound 2-azido-[K-32P]ADP can be cova-
lently bound under these conditions.
In order to test the e¡ect of covalent modi¢cation
on the ATP synthesis activity, the enzyme prepara-
tion was reconstituted into liposomes without or
after irradiation, and after a vpH/vB jump, the
rate of ATP synthesis was measured with 100 WM
ADP. Fig. 4B, left panel, shows the results: when
the sample was not irradiated, a rate of 155 s31
was observed. It decreased to 29 s31 after 45 s of
UV-irradiation. In order to distinguish the e¡ect of
covalent modi¢cation of a binding site from the po-
tentially harmful e¡ect of UV-irradiation on the pro-
tein, the enzyme without bound 2-azido-[K-32P]ADP
was also reconstituted and treated in the same way.
These results are shown in the right panel of Fig. 4B.
Up to an irradiation time of 30 s, the rate remains
constant at about 150 s31, and a small decrease is
observed after 45 s of irradiation.
Fig. 4C shows the rate of ATP synthesis as a func-
tion of the UV-irradiation time for CF0F1 and for
CF0F1, covalently modi¢ed with 2-nitreno-[K-
32P]ADP. These data clearly show that the decrease
of ATP synthesis is due to the covalent modi¢cation
of a nucleotide binding site and not to an unspeci¢c
e¡ect of UV-irradiation. Fig. 4D shows the rate of
ATP synthesis at di¡erent levels of covalently bound
2-nitreno-[K-32P]ADP (data from Fig. 4A,C). The
curve extrapolates to zero activity, when 0.95 mol
2-nitreno-[K-32P]ADP are covalently bound per mol
CF0F1. When EDTA was used instead of MgCl2
during the 30 min of incubation, the same results
were obtained.
3.4. Localisation of the bound 2-nitreno-ADP
When an enzyme preparation, treated with radio-
active 2-azido-ADP in the presence of 2 mM EDTA
for 30 min and illuminated for 45 s, was subjected to
sodium dodecylsulfate-gel electrophoresis, autora-
Fig. 3. Scheme of the di¡erent procedures for speci¢c labelling of the di¡erent catalytic sites. For didactic reasons the resulting nucleo-
tide occupation patterns are already shown in this scheme, although the arguments for the assignment are given in the Section 4.
BBABIO 44802 29-12-99
F.E. Possmayer et al. / Biochimica et Biophysica Acta 1456 (2000) 77^98 83
Fig. 4. E¡ect of UV-irradiation on ATP synthesis and covalent binding of 2-azido-[K-32P]ADP. CF0F1 (5 WM) was incubated with 50
WM 2-azido-[K-32P]ADP for 30 min, and free nucleotides were removed by three consecutive passages through centrifugation columns.
The enzyme was irradiated by UV-light for di¡erent times. (A) CF0F1 was denatured, and the amount of covalently bound 2-azido-
[K-32P]ADP was determined as a function of irradiation time. (B) After irradiation, the enzyme was reconstituted into liposomes, and
ATP synthesis was measured. CF0F1 concentration in the assay was 5 nM. The data on the left show the amount of ATP synthesised
by enzymes containing one 2-azido-[K-32P]ADP before irradiation. As a control, CF0F1 containing no 2-azido-[K-32P]ADP was sub-
jected to the same procedure. These data are shown on the right. The numbers at the curves give the initial rates of ATP synthesis in
s31. (C) The rates of ATP synthesis are shown as a function of irradiation time for CF0F1 (open squares) and for CF0F1 with cova-
lently bound 2-azido-[K-32P]ADP (¢lled squares)(data from B). (D) The rate of ATP synthesis is shown as a function of covalently
bound 2-azido-[K-32P]ADP (data from A and C). The ¢lled squares are the measured data, the open squares represent data, which are
corrected for the UV-e¡ect on CF0F1.
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diography of the gel revealed exclusive labelling of
the L-subunit (data not shown) in accordance with
earlier observations [9^14]. The protein was then di-
gested with trypsin, and the resulting peptides were
separated by HPLC.
Fig. 5 (upper panel) shows the elution pro¢le of an
HPLC anion exchange column run obtained with
such a preparation. The bars represent the radioac-
tivity of the collected fractions. The solid line indi-
cates the concentration of eluent B (see Section 2).
The expected regions for nitreno-AMP, nitreno-ADP
and nitreno-ATP containing peptides are indicated.
No nitreno-ATP-labelled peptides were found, and
the nitreno-AMP-labelled peptides represent less
than 15% of the total radioactivity, taking into ac-
count that also the radioactivity in the void volume
appeared to represent nitreno-AMP-labelled pepti-
des. Almost all radioactivity eluted as nitreno-
ADP-labelled peptides. Fraction 26 was subjected
to a second HPLC separation, using a reversed phase
column.
Fig. 5 (lower panel) shows the elution pro¢le
of the reversed phase column run. The peptide eluted
in fraction 30 (major peak) was used for amino
acid sequencing. This sequence was identi¢ed as
360GI-PAVDPLDSTST...378, being part of the L-sub-
unit. The empty position is that of the modi¢ed ami-
no acid Tyr-362. This 32P-labelled peptide is part of
the catalytic binding site, according to Xue et al.
[13,14]. Analysis of other fractions, eluted between
28 and 34 min, resulted in the ¢nding of the same
modi¢cation. The fractions 31^34 of the ion ex-
change oligomatography contained, in addition,
free nitreno-ADP, which was eluted in the void vol-
ume of the reversed phase column. Also, the nitreno-
AMP labelled-peptides were separated with reversed
phase chromatography, and they eluted between
fractions 26 and 32, characteristic for the peptide
containing Tyr-362. No label was found in the void
volume.
When samples were analysed after incubation with
2-azido-[K-32P]ADP in the presence of 2 mM MgCl2
(procedure 1), the same results were obtained, indi-
cating that indeed the same site is modi¢ed under the
two conditions.
CF0F1 was also incubated with 50 WM 2-azido-[K-
32P]ATP in the presence of 2 mM MgCl2 as well as in
the presence of 2 mM EDTA. The result in both
cases was that slightly more than one 2-azido-[K-
32P]AXP per CF0F1 was bound, and approximately
70% of the label was covalently bound after irradi-
ation. HPLC analysis of the labelled peptides with
anion exchange chromatography showed that ap-
proximately 30^40% of 32P-labelled peptides eluted
as nitreno-AMP-labelled peptides (largely appearing
in the void volume), 50% as nitreno-ADP-labelled
peptides and 10^20% as nitreno-ATP-labelled pepti-
des.
In the reversed phase HPLC, the nitreno-ADP-
and nitreno-AMP-labelled fractions eluted between
Fig. 5. HPLC elution pro¢les of photolabelled CF0F1 after
trypsin treatment. CF0F1 (5 WM) was incubated with 2-azido-
[K-32P]ADP in the presence of 2 mM MgCl2. Free nucleotides
were removed by three consecutive passages through centrifuga-
tion columns, and 2-azido-[K-32P]ADP was covalently bound to
CF0F1 by irradiation for 30 s. The photolabelled CF0F1 was
treated with trypsin, and the resulting labelled peptides were
separated by HPLC. The radioactivity of the collected fractions
is represented by bars. The elution gradients in percent of elu-
ent B are superimposed (right-hand scale). The upper panel
shows the separation of the labelled peptides with the ion ex-
change column. The elution regions for the peptides with di¡er-
ent adenosine phosphates are indicated. The lower panel depicts
the result of the separation of ADP-modi¢ed peptides (fraction
26 from A) on a reversed phase column. Amino acid sequence
analysis was carried out with fraction 30 indicating that Tyr-
362 of the L-subunit was labelled with ADP.
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28 and 32 min, i.e. at 28^32% eluent B, while the
nitreno-ATP-labelled peptides eluted between 18
and 20 min, i.e. at 18^20% eluent B. By amino acid
sequence analysis, the nitreno-ADP and nitreno-
AMP labels were detected on Tyr-362, and the nitre-
no-ATP label was found on Tyr-385 of the L-subunit
in the sequence IVGEEH-EI. According to Xue et al.
[13,14], Tyr-385 is indicative for a non-catalytic site.
These data show that incubation with 2-azido-[K-
32P]ATP is not appropriate for speci¢c modi¢cation
of catalytic sites, and that only incubation with 2-
azido-[K-32P]ADP causes selective binding to and co-
valent modi¢cation of a catalytic site.
3.5. E¡ect of modi¢cation of the loose catalytic site
on the kinetics of the enzyme
As discussed later in detail, the modi¢ed catalytic
site may be identi¢ed with the loose catalytic site.
This site is not occupied in the isolated enzyme and
binds a nucleotide quite strongly, after appropriate
incubation. To further characterise its features, we
investigated the e¡ect of the covalent derivatisation
of this site on the catalytic properties of the enzyme.
CF0F1 containing one 2-azido-[K-32P]ADP (proce-
dure 1) was irradiated for 45 s to achieve maximal
derivatisation (0.7 2-nitreno-[K-32P]ADP per CF0F1).
Then both the irradiated enzyme and, as a control,
the non-irradiated enzyme were reconstituted into
liposomes. ATP synthesis was measured after a
vpH/vB jump with the luciferin/luciferase assay as
described in Section 2 at ADP concentrations be-
tween 10 nM and 100 WM (Fig. 6, left). The initial
rates of ATP synthesis, as a function of the ADP
concentration, are depicted in Fig. 6, right. At low
ADP concentrations (upper panel), covalently modi-
¢ed and non-modi¢ed CF0F1 showed almost the
same rate of ATP synthesis. At higher ADP concen-
Fig. 6. ATP synthesis by CF0F1-liposomes after labelling with covalently bound and with non-covalently bound 2-azido-[K-32P]ADP
at di¡erent ADP concentrations. Left: ATP synthesis was measured as a function of reaction time after a vpH/vB jump. The CF0F1
contained one 2-azido-[K-32P]ADP either covalently bound (irradiated) or non-covalently bound (control). The curves indicate the
ATP concentration before and after the jump as measured by the luciferin/luciferase assay. The slope at t = 0 is the initial rate of
ATP synthesis, and the numbers give the initial rates in nM s31. Right: rate of ATP synthesis as a function of ADP concentration
from uni-site (upper panel) to multi-site condition (lower panel). Open triangles represent data with non-covalently bound 2-azido-
[K-32P]ADP, ¢lled triangles data with covalently bound 2-azido-[K-32P]ADP.
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trations, the rate of the modi¢ed CF0F1 decreased to
20^30% of the rate obtained with the non-modi¢ed
CF0F1.
ATP hydrolysis by irradiated and non-irradiated
enzyme was measured at di¡erent ATP concentra-
tions after activation by a vpH/vB jump [20], as
described in Section 2. Fig. 7, left shows a few exam-
ples of these measurements. The base line indicates
the constant luminescence corresponding to the ATP
concentration in the luciferin/luciferase assay. At
t = 0, the signal jump indicates the dilution of the
assay mixture by the injection of dithiothreitol-
treated proteoliposomes. The H-translocation and
catalytic reaction were rapidly uncoupled and ATP
hydrolysis started. The initial rates of ATP hydroly-
sis, as a function of ATP concentration, are depicted
in Fig. 7, right. At low ATP concentrations (upper
panel), covalently and non-covalently modi¢ed
CF0F1 gave almost the same rate of ATP hydrolysis.
At higher ATP concentrations, the rate of the cova-
lently modi¢ed CF0F1 decreased to 20^30% of the
rate of the non-modi¢ed enzyme. These data indicate
that covalent labelling of the catalytic site 2 neither
inhibits uni-site ATP synthesis nor uni-site ATP hy-
drolysis. Multi-site ATP synthesis and multi-site
ATP hydrolysis are inhibited proportional to the
fraction of covalently labelled enzyme.
3.6. Modi¢cation of the open binding site (site 3)
Fig. 8, left shows the nucleotide content as a func-
tion of incubation time, when the enzyme is incu-
bated with 100 WM 2-azido-[K-32P]ADP in bu¡er A
with 2 mM EDTA. Initially, the binding of 2-azido-
[K-32P]ADP was observed, reaching a level of one 2-
azido-[K-32P]ADP per enzyme after 30^40 min. One
of the initially bound nucleotides slowly dissociates
o¡, so that after incubation for 1.5 h with 2-azido-[K-
32P]ADP, in total again three nucleotides remained
bound. Two of the initially bound nucleotides remain
(about 1 ATP and 1 ADP), and the newly bound 2-
azido-[K-32P]ADP is derived from the medium and
bound at an empty site. The binding of 2-azido-
ADP in the presence of EDTA for 1.5 h is called
procedure 2. It should be reminded that, after 30
min of incubation, analysis of nucleotide content
gives the same result for incubation with EDTA
and for incubation with MgCl2 (procedure 1, see
Fig. 7. ATP hydrolysis by CF0F1 with covalently bound and with non-covalently bound 2-azido-[K-32P]ADP at di¡erent ATP concen-
trations. Left: ATP hydrolysis as a function of reaction time after a vpH/vB jump. The CF0F1 contained one 2-azido-[K-32P]ADP ei-
ther covalently bound (irradiated) or non-covalently bound (control). The curves indicate the ATP concentration before and after the
jump as measured by the luciferin/luciferase assay. The slope at t = 0 is the initial rate of ATP hydrolysis, and the numbers give the
initial rates in nM s31. Right: rate of ATP hydrolysis as a function of ATP concentration from uni-site (upper panel) to multi-site
condition (lower panel). Open triangles represent data with non-covalently bound 2-azido-[K-32P]ADP, ¢lled triangles data with cova-
lently bound 2-azido-[K-32P]ADP.
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Table 1), and in both cases L-Tyr-362 is covalently
labelled. Nucleotide analysis after 1.5 h of incubation
is shown in Table 1, procedure 2. The data from Fig.
8 and Table 1 indicate that with procedures 1 and 2,
one site is occupied by 2-azido-[K-32P]ADP, and that
L-Tyr-362 is covalently labelled in both cases. In
contrast to procedure 1, after procedure 2 the en-
zyme contains only two of the initially bound nucleo-
tides, one ATP and one ADP. Measurements of ATP
synthesis and ATP hydrolysis after covalent modi¢-
cation give the same result as documented for the
enzyme treated by procedure 1 (Figs. 4, 6 and 7).
We therefore conclude that with procedure 2, the
same site (site 2) is labelled as with procedure 1.
We then substituted the 2-azido-[K-32P]ADP used
in procedure 2 by ADP under identical incubation
conditions. The nucleotide analysis of this incubation
is shown in Table 1, ¢rst part of procedure 3. The
result of this incubation was an enzyme containing
1 ATP and 2 ADP, and we assume that the newly
bound ADP is located at the same site (site 2) as the
2-azido-[K-32P]ADP in the previous incubation (pro-
cedure 2). The pretreated enzyme was then subjected
to a second incubation, for 1 h, in the presence of
2 mM MgCl2 and di¡erent concentrations of 2-azi-
do-[K-32P]ADP (see Fig. 8, right). At 30 WM 2-azido-
[K-32P]ADP, the newly occupied site was already
completely ¢lled, and since the endogenous nucleo-
tide content did not change, we obtained four bound
nucleotides per CF0F1 (see Fig. 8, right). The nucleo-
tide analysis of the enzyme incubated with 100 WM 2-
azido-[K-32P]ADP revealed that the enzyme con-
tained 1.0 ATP, 1.9 ADP and 1.1 2-azido-[K-
32P]ADP per CF0F1 (procedure 3, see Table 1). Since
the non-labelled ADP bound with procedure 1 or 2,
remains bound during the second incubation period
of procedure 3, the 2-azido-[K-32P]ADP that is
bound during this second incubation is bound at a
di¡erent site.
After covalent labelling, the enzyme was digested
with trypsin, and the peptides were separated by
HPLC. Not only was the extent of covalent modi¢-
cation lower (50% instead of 75%), but the elution
pro¢le of anion exchange chromatography was also
di¡erent. As documented in Fig. 9 (upper panel),
peaks appeared at the positions of nitreno-AMP-
Fig. 8. Binding of 2-azido-[K-32P]ADP to CF0F1. Left : isolated CF0F1 (5 WM) was incubated with 100 WM 2-azido-[K-32P]ADP in the
presence of 2 mM EDTA for up to 90 min. After di¡erent incubation times, free nucleotides were removed by three consecutive pas-
sages through centrifugation columns. The upper panel shows the binding of 2-azido-[K-32P]ADP and total nucleotide content. After
1.5 h, about one 2-azido-[K-32P]ADP was bound to CF0F1 and one endogenous nucleotide (mostly ATP) was released. Right: the en-
zyme was incubated with 100 WM ADP and 2 mM EDTA for 1.5 h (see left) and then subjected to a second incubation with 2 mM
MgCl2 and di¡erent concentrations of 2-azido-[K-32P]ADP for 1 h. The upper panel shows the binding of 2-azido-[K-32P]ADP and to-
tal nucleotide content. The lower panel shows the content of endogenous nucleotides.
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Table 1
Characterisation of isolated CF0F1 and of CF0F1 reconstituted into liposomes and analysis of covalently bound nucleotides after UV-irradiation
Incubation conditions Isolated CF0F1 CF0F1 reconstituted into liposomes Analysis of irradiated CF0F1
ATPbound ADPbound ADPfree 2-N3-[K-32P]-
AXP
ATPbound ADPbound ADPfree 2-N3-[K-32P]-
AXP
Covalently
labelled
CF0F
% AXP labelled
peptide
Labelled
Tyr
Bu¡er A, 30 min 1.75 1.30 0.015 0 0.70 1.45 0.45 0 ^ ^ ^
Procedure 1
Incubation in bu¡er A
+2 mM MgCl2
+100 WM 2-N3-[K-32P]ADP
(30 min)
1.60 1.40 0.01 0.9 1.40 1.20 0.35 0.85 0.75 ADP
AMP
s 90%
6 10%
Y-362
Procedure 2 1.15 1.05 0.07 1.1 0.70 0.80 0.40 0.85 0.80 ADP Y-362
Incubation in bu¡er A
+2 mM EDTA
+100 WM 2-N3-[K-32P]ADP
(1.5 h)
Procedure 3 1.1 2.0 0.01 0 nd nd nd nd
Incubation in bu¡er A
+2 mM EDTA
+100 WM ADP (1.5 h)
Column centrifugation
Incubation in bu¡er A
+2 mM MgCl2
+100 WM 2-N3-[K-32P]ADP
1 h
1.0 1.9 0.05 1.1 0.8 1.8 0.3 0.95 0.50 AMP
ADP
ATP
58%
40%
2%
Y-362
Y-362
Data are given in mol nucleotide per mol CF0F1. No free ATP was detected under any condition. The % of AXP-labelled peptides is given as percent of radioactivity
of the sample applied on the ion exchange column. Incubations were carried out at room temperature. After each incubation, free nucleotides were removed by three
consecutive passages of the CF0F1 solution through centrifugation columns; nd, not determined. The data for the initial conditions (bu¡er A, 30 min) represent the
average of 12 preparations, the data for procedure 1 resulted from three experiments, for procedure 2 from twelve and for procedure 3 from four experiments. The
standard deviation was less than 10% for all the data shown.
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and nitreno-ADP-labelled peptides, and a large frac-
tion of the radioactivity was eluted in the void vol-
ume. The fraction in the void volume contained free
nitreno-AMP and nitreno-AMP-labelled peptides,
because the binding of nitreno-AMP-labelled pepti-
des to the column is weak. Subsequent analysis of
pooled fractions (fractions 1^7, 17^19 and 26^27) on
a reversed phase column showed that the elution
pro¢le was identical for all samples, characteristic
for a modi¢ed catalytic site (Fig. 9, upper and lower
panels). Sequence analysis con¢rmed that the L-Tyr-
362 was modi¢ed in all samples. A very small frac-
tion of the radioactivity (2%) eluted as nitreno-ATP-
labelled peptide. When the nitreno-ATP-labelled
peptide was subjected to reversed phase HPLC, it
eluted between fraction 16 and 18, which is indicative
for modi¢cation of the L-Tyr-385 of the non-catalytic
site. The labelling of L-Tyr-362 proves that the 2-
azido-[K-32P]ADP was bound at a catalytic site,
and the di¡erence in labelling e⁄ciency as well as
the di¡erence in the AMP/ADP ratio of the labelled
peptides con¢rm that this site is di¡erent from site 2.
In the following, it is called site 3 (open site) (see
Section 4).
3.7. E¡ect of modi¢cation of the open catalytic site on
enzyme activity
After covalent binding of 1.1 2-azido-[K-32P]ADP
per CF0F1 the enzyme was treated by UV for di¡er-
Fig. 9. HPLC elution pro¢les of CF0F1 peptide fragments derived from catalytic site 3. CF0F1 was incubated as described under pro-
cedure 3. Bound 2-azido-[K-32P]AXP was covalently bound to CF0F1 by UV-irradiation for 30 s. The photolabelled CF0F1 was
treated with trypsin, and the resultant labelled peptides were separated by HPLC. The radioactivity of the collected fractions is repre-
sented by bars. The elution gradients in percent of eluent B are superimposed (right-hand scale). Upper left panel : separation of the
labelled peptides with the ion exchange column (IE). The elution regions for the peptides with di¡erent adenosine phosphates are indi-
cated. Lower left panel: result of the separation of the ion-exchange fractions 1^7 by reversed phase chromatography (RP). Upper
right panel: RP elution pro¢le of the separation of the -AMP modi¢ed fractions (ion exchange fractions 17^19). Lower right panel :
RP elution pro¢le of the separation of the -ADP modi¢ed peptides (ion exchange fractions 26^27).
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ent irradiation times. The fraction of covalently
bound nitreno-ADP increases with increasing UV-ir-
radiation time up to maximal 0.47 2-nitreno-[K-
32P]AXP per CF0F1 after 30 s, and a further increase
of the irradiation time did not change this value. In
contrast, irradiation of the enzyme subjected to pro-
cedure 1 or 2 (i.e. occupation of site 2) caused the
binding of 0.7^0.8 2-nitreno-AXP per enzyme. This is
the ¢rst di¡erence between sites 2 and 3.
The covalently labelled and the non-covalently la-
belled CF0F1 complexes were reconstituted into lipo-
somes, and enzyme activity was measured. Fig. 10
shows that the rate of ATP synthesis (ADP concen-
tration: 100 WM) is inhibited progressively with in-
creasing level of covalent modi¢cation of the CF0F1.
Extrapolation of the linear part of the curve indicates
that full inhibition is achieved when one nucleotide
per CF0F1 is covalently bound.
Fig. 11 shows the rate of ATP synthesis, as a
function of the ADP concentration. At low ADP
concentrations (upper panel), no inhibition by cova-
lent labelling was observed. At higher concentrations
(100 WM ADP, lower panel), the modi¢cation in-
duced a decrease of the rate of synthesis by about
a factor of 2. The inhibition started at about 500 nM
ADP, i.e. in the concentration range between uni-site
and multi-site ATP synthesis (center panel).
Fig. 12 shows the rate of ATP hydrolysis for dif-
ferent ATP concentrations. Again, at low ATP con-
centrations (upper panel), no inhibition was ob-
served, whereas at 1 WM ATP (lower panel) there
was an inhibition of about 50%. Multi-site ATP hy-
drolysis at 1 mM ATP (data not shown) decreased
from 15 to 7 s31.
In Table 1, the data from the analysis of bound
Fig. 10. E¡ect of covalent binding of 2-azido-[K-32P]ADP to
CF0F1 on the rate of ATP synthesis after reconstitution into
liposomes. CF0F1 (5 WM) was incubated as described under
procedure 3. The enzyme contained 0.8 ATP, 1.8 ADP and
0.95 2-azido-[K-32P]AXP bound per CF0F1 and was covalently
labelled by UV-irradiation for di¡erent times (see Table 2).
After reconstitution of the di¡erently labelled enzymes, the rate
of ATP synthesis was measured as a function of covalently
bound 2-azido-[K-32P]ADP per CF0F1. CF0F1 concentration in
the assay was 5 nM.
Fig. 11. Rate of ATP synthesis of CF0F1 with covalently bound
and non-covalently bound 2-azido-[K-32P]ADP at site 3 at dif-
ferent ADP concentrations. CF0F1 was incubated as described
under procedure 3. After removal of free nucleotides, CF0F1
contained 0.47 2-azido-[K-32P]AXP covalently bound (¢lled tri-
angles) or 1.1 non-covalently bound 2-azido-[K-32P]ADP per
CF0F1 (open triangles). CF0F1 concentration in the assay was
35 nM. The upper panel shows the rate of ATP synthesis under
uni-site conditions (up to 200 nM ADP). The lower panel
shows the data under multi-site conditions (up to 100 WM). The
center panel shows the intermediate range.
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nucleotides after various treatments of CF0F1 are
collected, including the e¡ects of reconstitution and
UV-irradiation on the nucleotide content. The data
show that during reconstitution part of the ATP dis-
appeared from the enzyme. Free ATP was not de-
tected under any condition described. This implies
that some of the bound ATP is converted to ADP
and released as ADP. Correspondingly, the total nu-
cleotide content (initially bound ones and 2-azido-
[K-32P]AXP) decreased during reconstitution. The
analysis of the labelled peptides derived from the
irradiated CF0F1 samples reveals that with proce-
dures 1^3, L-Tyr-362 is always labelled. For proce-
dures 1 and 2, the fraction of labelled CF0F1 as well
as the nitreno-AMP- and nitreno-ADP-labelled pep-
tide fractions are the same within the error limits of
the experiments. For procedure 3, both parameters
are di¡erent, and this indicates occupation of a cata-
lytic site di¡erent from that labelled with procedures
1 and 2.
3.8. Release of non-covalently bound nucleotides by
energisation
After reconstitution of CF0F1 with the non-cova-
lently bound 2-azido-[K-32P]ADP into liposomes, the
reconstituted CF0F1 contained 0.85^0.95 2-azido-
[K-32P]ADP per enzyme (see Table 1). We investi-
gated the release of the radioactive nucleotides
upon energisation of the membrane by vpH/vB in
the presence and in the absence of substrates (see
Section 2). When the enzyme was treated according
to procedure 1 or 2, the release of 0.18 2-azido-
[K-32P]AXP CF0F1 was measured. In the presence
of substrate (100 WM ADP, synthesis direction),
0.25 2-azido-[K-32P]AXP CF0F1 was released, and
the same result was obtained upon addition of
1 mM ATP (hydrolysis direction). When the enzyme
was treated according to procedure 3, 0.1 2-azido-
[K-32P]AXP per CF0F1 was released. In the presence
of substrate, either 1 mM ATP or 100 WM ADP,
approximately 0.18 of the bound radioactive nucleo-
Fig. 12. Rate of ATP hydrolysis of CF0F1 with covalently
bound and non-covalently bound 2-azido-[K-32P]AXP at the
open catalytic site at di¡erent ATP concentrations. CF0F1 was
incubated, as described under procedure 3, resulting in the
same occupation pattern of nucleotides as given in Fig. 11. The
rate of ATP hydrolysis was measured after activation of the en-
zyme by a vpH/vB jump from uni-site (upper panel) to multi-
site (lower panel) conditions. CF0F1 concentration in the assay
was 35 nM. Open triangles represent data with non-covalently
bound 2-azido-[K-32P]AXP. Filled triangles represent data with
covalently bound 2-azido-[K-32P]AXP.
Table 2
Release of non-covalently bound 2-N3-[K-32P]AXP in vpH/vB jump
Incubation conditions Non-covalently
bound 2-N3-[K-32]AXP
2-N3-[K-32P]AXP released in
vpH/vB jump without substrate
2-N3-[K-32P]AXP released in vpH/vB jump
with substrate
Hydrolysis
+1 mM ATP
Synthesis
+100 WM ADP
Procedure 1 0.9 0.18 0.25 0.25
Procedure 3 0.95 0.10 0.17 0.19
CF0F1 (5 WM) was treated as described in procedure 1 or procedure 3 and then reconstituted into liposomes. Energisation of the
membrane leads to the release of the non-covalently bound 2-azido-[K-32P]ADP. Free nucleotides were separated by rapid ¢ltration
from the liposomes 5 s after energisation. Experiments were carried out in the absence of substrates or in the presence of substrates,
either 1 mM ATP or 100 WM ADP. Data are given in mol nucleotide per mol CF0F1
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tide was released per CF0F1. All these data are col-
lected in Table 2. They show that 10^15% of the
bound radioactive nucleotides are released in the ab-
sence of substrates and 20^25% in the presence of
either ADP or ATP.
This is surprising since during the 5 s passing be-
tween energisation and separation of the enzyme
from the released nucleotides, more than 500 ATP
are newly synthesised per CF0F1 with an ADP con-
centration of 100 WM (see Fig. 6). In hydrolysis di-
rection at 1 mM ATP, about 80 ATP per CF0F1 are
hydrolysed within 5 s. If the radioactive nucleotide is
located on a site involved in the catalytic reaction
cycle, a complete loss of the label is expected within
a few turnovers. Obviously, this was not the case;
only 20^25% of the enzymes lost the label during
turnover. We must conclude from this result that
only about 25% of the enzymes participate in the
catalytic reaction cycle.
4. Discussion
4.1. Occupation of the di¡erent nucleotide binding
sites
In earlier work on the characterisation of nucleo-
tide binding sites, the binding a⁄nity and the ex-
changeability of nucleotides were used to classify
binding sites [37,38]. An important step forward
was the result that covalent binding of 2-azido-
[K-32P]AXP occurs on L-Tyr-362 for catalytic sites
and on L-Tyr-385 for non-catalytic sites [13,14,
23,41]. The X-ray structure revealed that L-Tyr-362
is in fact located on the L-subunit, whereas the label-
ling of L-Tyr-385 indicates binding on a loop from a
L-subunit which is part of a non-catalytic nucleotide
binding site on the K-subunit [15]. Throughout this
work, we used the labelling of L-Tyr-362 as an in-
dication for binding at a catalytic site on the L-sub-
unit. With this approach, two properties of the cata-
lytic sites could be revealed:
(1) When isolated CF0F1 was incubated with
2-azido-[K-32P]ADP, L-Tyr-362 was labelled in the
presence of Mg2 as well as in the presence of
EDTA. The covalently bound nucleotide at L-Tyr-
362 was predominantly ADP.
(2) When isolated CF0F1 was incubated with
2-azido-[K-32P]ATP, mainly L-Tyr-362 was labelled,
however, also some labelled L-Tyr-385 was found.
Binding occurred in the presence of Mg2 as well
as in the presence of EDTA. The covalently bound
nucleotide at L-Tyr-362 was predominately ADP and
some AMP, the covalently bound nucleotide at L-
Tyr-385 was ATP.
We would like to emphasise that in none of the
many sequencing rounds any other amino acids than
Tyr-362 or Tyr-385 were found, not even low levels
of other labelled amino acids. In the eluate from the
ion exchange chromatography, we never found any
nitreno-ADP-modi¢ed peptide with modi¢ed Tyr-
385. Part of the label in the fractions with nitreno-
ADP was, however, free nitreno-ADP. This was the
case with the fractions 31^36 of Fig. 5, upper panel.
On a subsequent reversed phase chromatography,
most labels in these fractions eluted in the void vol-
ume. There were only two populations of label in the
nitreno-ADP region of the ion exchange chromatog-
raphy: nitreno ADP that is covalently bound at Tyr-
362 or free nitreno-ADP. The nitreno-AMP fractions
contain only a covalently bound label and no free
nitreno-AMP, indicating that the formation of nitre-
no-AMP occurs after covalent binding of the azido-
ADP as nitreno-ADP and it is presumably not the
result of adenylate kinase activity.
These data show that isolated CF0F1 binds ADP
selectively on catalytic sites of the L-subunits. ATP
binds to both catalytic and non-catalytic sites. When
ATP is bound to catalytic sites, it is hydrolyzed to
ADP, whereas ATP bound to non-catalytic sites is
not hydrolyzed. Therefore, in this work we have only
used incubations with 2-azido-[K-32P]ADP for selec-
tive labelling of catalytic sites. Based on these ¢nd-
ings, we can now interpret the distribution of the
initially bound nucleotides on CF0F1. The CF0F1
used in this work contained 1 ADP and 2 ATP per
enzyme after isolation (see Table 1), and we conclude
that ADP is bound at a catalytic site while the two
ATP’s are bound at non-catalytic sites.
The nucleotide binding sites have di¡erent proper-
ties. In order to distinguish the di¡erent catalytic
sites, we call them sites 1, 2 and 3 in order of de-
creasing a⁄nity for ADP, i.e. site 1 has the lowest
dissociation constant for ADP, site 3 has the highest
and site 2 has an intermediate dissociation constant
[27]. This is the same nomenclature as used for de-
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scription of the dissociation constants of ADP (and
ATP) in catalytic sites of the F1-part from E. coli
H-ATPase [55]. Correspondingly, the three non-cat-
alytic sites are called 4, 5 and 6 in order of decreasing
a⁄nity for ATP. Based on this classi¢cation, it is
clear that the ADP at the catalytic site is localised
on site 1 since, per de¢nition, this is the site with the
lowest dissociation constant. Similarly, the ATP on
the non-catalytic site must be localised on sites 4 and
5, since these have the lower dissociation constants.
These considerations lead to the distribution of ini-
tially bound nucleotides depicted in Fig. 3 (upper
panel).
When a sample of isolated CF0F1 with such a
nucleotide occupation is incubated with 2-azido-[K-
32P]ADP, this ADP analogue binds to the catalytic
binding site with the medium dissociation constant
(site 2). The stoichiometry and also the kinetics of
binding indicate that with procedure 1 only one addi-
tional site is ¢lled (Fig. 2), and analysis of covalent
labelling shows that this is a catalytic site (Fig. 5).
The endogenous nucleotide content does not change
during procedure 1. The resulting distribution of nu-
cleotides is shown in Fig. 3 (procedure 1).
Prolonged incubation of CF0F1 with 2-azido-[K-
32P]ADP in the presence of EDTA leads ¢rst to the
binding of 2-azido-[K-32P]ADP, followed by the re-
lease of ATP (and some ADP) (see Fig. 8). As with
procedure 1, 2-azido-[K-32P]ADP is bound to site 2,
and ATP is released from the occupied non-catalytic
site with the highest dissociation constant, i.e. from
site 5. The resulting state of nucleotide occupation is
shown in Fig. 3 (procedure 2). With this enzyme
species we have carried out the same experiments
as described in Figs. 4^7 for CF0F1 pretreated ac-
cording to procedure 1, and the same results were
obtained (data not shown). We conclude that with
both procedures, the same catalytic site (site 2) binds
2-azido-[K-32P]ADP, however, CF0F1 has lost one
endogenous ATP from site 5 after treatment with
procedure 2. Obviously, this loss has no e¡ect on
the parameters measured in the experiments shown
in Figs. 4^7.
We then used the same incubation conditions
again, except that 2-azido-[K-32P]ADP was replaced
by ADP. The nucleotide analysis revealed that one
additional ADP was bound and one ATP was re-
leased (see Table 1). We assume that incubation
with ADP generates the same nucleotide distribution
as incubation with 2-azido-[K-32P]ADP (see Fig. 3,
procedure 3). When the enzyme pretreated in this
way is further incubated with 2-azido-[K-32P]ADP
in the presence of Mg2, one 2-azido-[K-32P]ADP is
additionally bound without further change in the ini-
tial nucleotide content (see Table 1). Since upon illu-
mination L-Tyr-362 is covalently modi¢ed, the newly
bound 2-azido-[K-32P]ADP must therefore be located
on the catalytic site 3, since sites 1 and 2 are already
¢lled with ADP. The resulting distribution of nucleo-
tides is shown in Fig. 3, procedure 3.
4.2. Properties of catalytic sites 2 and 3
While covalent modi¢cation indicates that both
sites discussed here are catalytic sites, the quantita-
tive results di¡er in two respects: ¢rst, the degree of
covalent labelling is di¡erent; and second, the type
of covalently bound nucleotide is di¡erent. When site
2 is occupied (after treatment with procedure 1 or 2),
UV-irradiation of the samples for 45 s causes cova-
lent binding of 0.7^0.8 mol 2-nitreno-AXP per mol
enzyme, whereas only 0.5 mol per mol are covalently
bound in samples when site 3 is occupied (procedure
3), although the ratio for non-covalent binding of
2-azido-[K-32P]ADP is about 1 for both sites (see
Table 1). One explanation might be that the structure
of the site 3 di¡ers from site 2 so that the distance
between the azido-group and Tyr-362 is slightly lon-
ger, resulting in a less e⁄cient modi¢cation. A sec-
ond explanation seems to be more attractive. Data
from Czarnecki et al. [9] show that in aqueous sol-
ution, azido-nucleotides are in equilibrium with a
non-photoreactive tetrazole form, and at neutral
pH, about half of the nucleotides are present in the
azido-form. Decreasing the polarity of the solvent
shifts the equilibium to the azido-form [9]. Therefore,
our data might indicate that binding site 2 has a
decreased polarity compared to water, whereas bind-
ing site 3 has a polarity similar to water, i.e. site 3
has an open structure with easy access to water.
Based on this consideration and on the fact that
site 1 has the highest a⁄nity for substrates (the ADP
on this site remains bound during all the treatments
described in this work), it is tempting to speculate
about the classi¢cation of the nucleotide binding sites
identi¢ed in this work as compared to the classi¢ca-
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tion used for describing the binding change mecha-
nism. In the binding change mechanism, it is as-
sumed that there are three identical catalytic sites
which sequentially adopt three di¡erent conforma-
tions during catalysis. They di¡er in their binding
a⁄nity to nucleotides and are characterised as tight,
loose and open [16,17,39]. It seems plausible to iden-
tify site 1 with the tight site, site 2 with the loose site
and site 3 with the open site. However, one must
keep in mind that the binding change mechanism
describes the active enzyme during catalytic turnover,
whereas our characterisation refers to the nucleotide
binding of the non-activated CF0F1. It may be that
after catalysis, e.g. when all substrates are consumed,
the enzyme is ‘frozen’ in a state similar to one of the
dynamic states during catalysis. In this case the as-
signment of sites made here would be correct. How-
ever, there are some reservations. In MF1, site 1 has
to contain ATP which remains bound during catal-
ysis [19]. With CF0F1, it is well established that the
inactive enzyme contains a tightly bound ADP which
has to be released by energisation before the enzyme
becomes active in catalysis [40]. This implies that site
1 to which the ADP is bound, is presumably not the
tight nucleotide binding site proposed in the binding
change mechanism, but something like a ‘degener-
ated’ catalytic site which becomes a normal catalytic
site only after release of the tightly bound ADP upon
energisation [22]. The characteristics of site 2 resem-
ble those of the loose site, and the properties of site 3
are similar to those expected for the open site. It
should be remembered that we did not detect a nu-
cleotide bound at site 3 as long as the non-catalytic
site 5 is occupied. When site 5 is occupied by ATP
(as during catalysis), the nucleotide binding at site 3
is so weak that nucleotides are lost during centrifu-
gation of the enzyme solution through the Sephadex
columns. Obviously, removal of ATP from site 5
changes the binding characteristics in such a way
that in the presence of Mg2, the ADP on site 3
remains bound, during separation of the free nucleo-
tides. This is an interesting property of ATP binding
to an K-subunit: It modi¢es the binding a⁄nity at a
catalytic site on the L-subunit.
Sites 2 and 3 di¡er not only with respect to the
degree of covalent binding, but also the analysis of
the type of covalently bound nucleotides revealed
di¡erences in their catalytic properties. When site 2
was occupied after treatment with procedure 1 or 2,
more than 90% of the covalently bound nucleotide
was ADP, the rest was AMP. Occupation of site 3
(procedure 3) yielded 58% AMP, 40% ADP and 2%
ATP; AMP and ADP were bound at L-Tyr-362
(Table 1). The formation of nitreno-AMP after
covalent binding of nitreno-ADP at a catalytic site
has been described earlier [30,27]. We have to con-
clude from these results that data in the literature
which are based on the use of 2-azido-ADP or 2-
azido-ATP with the radioactivity at the L-phospho-
rous position can be misleading, when a catalytic site
is modi¢ed, since part of the modi¢cation remains
undetected.
The amino acid sequencing of the ATP-labelled
peptide was not carried out, since not enough mate-
rial for analysis was obtained; however, the elution
pro¢le from the reversed phase column indicated that
this ATP was localised at a non-catalytic site. Obvi-
ously, the conformation of site 3 allows the hydro-
lysis of bound nitreno-ADP to a signi¢cantly higher
extent than at site 2. For MF1 an ADPase activity
has also been reported [31,41,44]. The observation of
a bound 2-nitreno-[K-32P]ATP at Tyr-385, i.e. at a
non-catalytic site is presumably not the result of an
adenylate kinase activity. The azido-[K-32P]ADP sol-
ution contained approximately 0.5% azido-[K-
32P]ATP, i.e. the concentration of azido-[K-32P]ATP
was 0.5 WM. The empty ATP binding site (site 5) on
the K-subunit becomes saturated with 2-azido-[K-
32P]ATP in the presence of Mg2 when its concen-
tration is 20 WM (in the absence of Mg2 bound
nucleotide dissociates form this site (unpublished ob-
servation)). When the dissociation constant is ap-
proximately 10 WM, one can calculate that with
0.5 WM azido-[K-32P]ATP and with an enzyme con-
centration of 4 WM about 3% of site 5 is occupied by
azido-[K-32P]ATP. This is almost the same occupa-
tion as found by the peptide analysis (see Table 1,
procedure 3). Di¡erent e⁄ciencies of AMP forma-
tion indicate di¡erent conformations of sites 2 and
3, i.e. this observation leads to the same conclusion
as that deduced from the di¡erent degrees of cova-
lent labelling. It should be mentioned that already in
the ¢rst report on bound nucleotides, besides ADP
and ATP also AMP was detected [42]; however, the
formation of AMP seems to be a side reaction not
involved in the catalytic cycle [43].
BBABIO 44802 29-12-99
F.E. Possmayer et al. / Biochimica et Biophysica Acta 1456 (2000) 77^98 95
4.3. Release of non-covalently bound
2-azido-[K-32P]ADP during energisation
Energisation of the liposome membrane by vpH/
vB induced the release of approximately 10% of the
non-covalently bound 2-azido-[K-32P]ADP (see Table
2). This might indicate that energisation generates a
new enzyme conformation which is characterised by
a higher dissociation constant of nucleotides bound
to sites 2 and 3 as compared to the inactive form.
When energisation was carried out in the presence of
substrates, i.e. during catalytic turnover, approxi-
mately 25% of non-covalently bound 2-azido-[K-
32P]ADP was released (Table 2). This number is sur-
prising since about 80 turnovers (ATP hydrolysis) or
500 turnovers (ATP synthesis) are carried out during
the assay, and a complete loss of the non-covalently
bound label is expected already within a few turn-
overs. We must conclude from this result that only
25% of the enzymes are involved in the catalytic re-
action. On the other hand, the stoichiometry and the
kinetics of the binding of 2-azido-[K-32P]ADP (Figs.
2 and 8) and the subsequent analysis of the cova-
lently labelled peptides showed that the di¡erent pro-
cedures developed in this work lead to a selective and
complete labelling of one site, i.e. to a homogene-
ously labelled CF0F1 preparation. Therefore, we as-
sume that the heterogeneity of the response of CF0F1
to membrane energisation results from the reconsti-
tution procedure, i.e. only 25% of the enzymes added
for reconstitution are correctly inserted into the
membrane, and only these are involved in catalysis.
The rest is not reconstituted or wrongly inserted into
the membrane. All enzyme activities (turnover, rate)
in this work are based on the amount of enzyme
added to the reconstitution medium, assuming that
all the enzymes are active in catalysis. If only 25% of
the added enzymes are active, all the rates given in
this work have to be multiplied by a factor of 4 in
order to obtain the rates based on the amount of
correctly reconstituted enzymes. The average rate of
ATP synthesis per enzyme added for reconstitution
was 120 þ 30 s31 (average rate from more than 100
reconstitutions with 12 di¡erent CF0F1 prepara-
tions). Using the amount of active enzyme deter-
mined by the release of 2-azido-[K-32P]ADP, we ob-
tain a rate of 480 þ 120 s31. Such rates have been
measured when thylakoid membranes are energised
by vpH/vB[36,45].
4.4. The e¡ect of covalent labelling on catalysis
Most work on correlation between the inhibition
of catalysis and the labelling with 2-azido-nucleotides
was carried out with the F1-part of the H-ATPases.
Such data give information on cooperativity between
nucleotide binding sites, when ATP hydrolysis is not
coupled with proton translocation. In the case of
CF1, there is evidence for a heterogeneous labelling
of the nucleotide binding sites and for a heterogene-
ous mechanism of ATP hydrolysis [23]. In a recent
work, the mitochondrial H-ATPase in submito-
chondrial membrane vesicles was labelled with 2-azi-
do-nucleotides [46]. ATP synthesis and ATP hydro-
lysis were inhibited, and a complete inhibition was
found when one catalytic site per mol F1 was la-
belled.
For such investigations, CF0F1 has several advan-
tages. The isolated enzyme can be reconstituted into
liposomes showing reasonable high rates of ATP
synthesis and ATP hydrolysis. This model system
contains only one protein, so that quantitative results
are easily obtained. Finally, the isolated CF0F1 is in
its inactive conformation and can only be trans-
formed into its active form by energisation of the
membrane after reconstitution. Therefore, enzyme
species with well-de¢ned occupation patterns of the
nucleotide binding sites can be prepared prior to re-
constitution, and their distribution of bound nucleo-
tides does not change during handling of the enzyme,
a serious problem with active enzymes.
UV-irradiation of CF0F1 for up to 30 s before
reconstitution had no detectable e¡ect on the rate
of ATP synthesis, irradiation for 45 s caused a de-
crease of about 10%. Non-covalent binding of 2-azi-
do-[K-32P]ADP to site 2 or 3 either with procedure 1
or 2 or 3 before reconstitution, did not a¡ect the rate
of ATP synthesis. Covalent binding of 2-azido-[K-
32P]ADP before reconstitution inhibited ATP synthe-
sis proportional to the degree of labelling. For site 2
as well as for site 3, extrapolation of the curve re-
vealed that inhibition is complete when one nucleo-
tide per enzyme is covalently bound (Figs. 4 and 10).
This implies that in multi-site catalysis, the catalytic
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sites operate sequentially and covalent labelling of
site 2 completely blocks ATP synthesis (and ATP
hydrolysis); the same is true for site 3. However, at
the lowest substrate concentrations used in this work,
neither inhibition of ATP synthesis (Figs. 6 and 11)
nor inhibition of ATP hydrolysis (Figs. 7 and 12) is
observed. Based on earlier work on uni-site and mul-
ti-site ATP hydrolysis catalysed by MF1 [47,48], we
have carried out similar investigations with reconsti-
tuted CF0F1 and with thylakoid membranes. Rate
constants for substrate binding, product release and
concentrations of bound nucleotides at the catalytic
site were measured for ATP hydrolysis and ATP syn-
thesis [49^51]. From these data, we conclude that at
the lowest substrate concentrations used in this work,
uni-site ATP synthesis (below about 100 nM ADP)
and uni-site ATP hydrolysis (below 10 nM ATP)
takes place. Therefore, the data presented in this
work show that neither uni-site ATP synthesis nor
uni-site ATP hydrolysis is inhibited by covalent mod-
i¢cation of site 2 or 3. When di¡erent subunits were
crosslinked in the F1-parts, a loss of cooperativity
was also observed. EF1 with crosslinked K- and L-
subunits contained only low a⁄nity catalytic sites
[52] and EF1 with a crosslink between Q- and L-sub-
units showed uni-site hydrolysis at a low a⁄nity site
[53]. Also a L^L-crosslink of the K3L3Q-complex from
PS 3 retained uni-site hydrolysis [54].
When site 2 is blocked, uni-site catalysis can pro-
ceed at site 1 or 3, or, when site 3 is blocked, it can
occur at site 1 or 2. Therefore, it is plausible to
assume that uni-site catalysis is restricted to site 1,
although this question cannot be answered de¢nitely
on the basis of the results reported here. The inhib-
ition studies show strong cooperative interactions be-
tween the catalytic nucleotide binding sites during
ATP synthesis and ATP hydrolysis under multi-site
conditions, i.e. a complete inhibition is observed
when one of the three sites is blocked by covalent
labelling. In contrast, for uni-site ATP synthesis and
ATP hydrolysis, there is no evidence for cooperative
e¡ects between nucleotide binding sites.
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